I am totally shell shocked beyond imagination that shares of CYDY are not up around $2.00/share with the announcement of IRB approval of the basket trial. If this was another budding bio pharma on the NYSE or the Nasdaq, it would have blown the doors off of it's stock.
CYDY is a feared company in bio-techs and it should be with all that they've attained so far with all that's going on, catalysts etc up the kazoo and we're still at $1.09, I digress